Head-to-head · WeighScore
Spry vs Vital Edge
The verdict
Vital Edge takes it — 65/100 to 56.8/100.
Vital Edge grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Vital Edge is a Chattanooga, TN telehealth practice offering physician-supervised GLP-1 weight loss nationwide by video, with medication shipped to your door each month.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Spry | Vital Edge |
|---|---|---|
| WeighScore | 56.8/100 | 65/100 |
| Grade | C | C |
| Scorecard rank | #408 | #229 |
| Semaglutide | $199/mo (starting dose, compounded) | $350/mo (compounded) |
| Tirzepatide | $299/mo (starting dose, compounded) | $450/mo (compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
Graded #408 · C
Strengths
- Three named co-founders disclosed (Gabriel Mullins, Sara Yoder, Tyler Bowman) — better-than-average transparency
- Pricing shown on the homepage ($199 semaglutide / $299 tirzepatide / $249–$299 peptides) — no full sign-up wall
- Broader range (2 GLP-1s plus 3 anti-aging peptides) appeals to longevity buyers
- No contracts or commitment required
- LegitScript Certified with a public verification link
Where it loses points
- Displays an "FDA Approved" badge though compounded GLP-1s are not FDA-approved finished drugs — potentially misleading
- Intake reviewed by a nurse practitioner, not an MD
- States served not disclosed publicly
- Pharmacy partner not named, and 503A vs 503B designation not specified
- FDA has issued this company a warning letter; the letter is public in FDA's warning-letter database
Graded #229 · C
Strengths
- Transparent flat monthly pricing published on-site — consult, medication, and shipping all included
- Broad menu: compounded semaglutide/tirzepatide, compounded oral capsules from $199/mo, plus brand-name Ozempic, Wegovy, Mounjaro and Rybelsus
- LegitScript-certified (seal #43281221)
- Flat fee with no upcharge as your dose increases
- Compounded oral GLP-1 capsules available for needle-free dosing
Where it loses points
- Compounded injectable pricing ($350 semaglutide / $450 tirzepatide) runs above the lowest-cost telehealth options
- No compounding pharmacy partner named on the site
- No named medical director or prescribing clinicians
- State availability not published — only a nationwide virtual-care claim
- Small, locally-rooted operation with a limited public track record
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.